WebEl organigrama de Theseus Pharmaceuticals muestra a sus 21 principales ejecutivos de los cuales Tim Clackson, Brad Dahms y David Kerstein ... Organizational Chart of Theseus Pharmaceuticals. Theseus Pharmaceuticals www.theseusrx.com. tieneposee 21 ejecutivos +1 212 739 6493;
Did you know?
WebMarch 10, 2024 and Theseus' Form 10-Q for the quarter ended March 31, 2024 expected to be filed with the SEC in the second quarter of 2024. However, new risk factors ... Brad Dahms. CFO. Former CFO, Selecta Biosciences ©2024 Theseus Pharmaceuticals. WebJun 2, 2024 · Theseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan-variant kinase inhibitors, today announced the appointment of Brad Dahms as Chief Financial Officer, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan …
WebFounder of Theseus Pharmaceuticals, Inc., Victor M. Rivera currently is Chief Scientific Officer at this company. In his past career Dr. Rivera held the position of VP-Preclinical & Translational Research at ARIAD Pharmaceuticals, Inc. He received a doctorate from Harvard Medical School and an undergraduate degree from Princeton University. WebBrad Dahms is Chief Financial Officer of Theseus Pharmaceuticals. Brad most recently served as Chief Financial Officer of Selecta Biosciences, Inc. (NASDAQ: SELB), where he oversaw financial operations, investor relations, and business development activities. He led Selecta through several significant financing and strategic transactions ...
WebTheseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan-variant kinase inhibitors, today announced the appointment of Brad Dahms as Chief Financial Officer. “Brad brings more than a decade of financial, business development, and strategic capital markets leadership expertise in the … WebCongratulations to Stern IR client, Disc Medicine, who announced this morning a $62.5M registered direct offering led by Bain Capital! #biotech…. Liked by Brad Dahms. …
WebAt Theseus Pharmaceuticals, Brad Dahms has 18 colleagues including Tim Clackson (CEO & Director), Kathy Yi (Director)… Industry Colleagues. In the Pharmaceuticals industry, Brad Dahms has 19,468 colleagues in 1,985 companies located in 70 countries.
WebJun 2, 2024 · Published: Jun 02, 2024. CAMBRIDGE, Mass., June 2, 2024 /PRNewswire/ -- Theseus Pharmaceuticals, a biotechnology company shaping the future of targeted … cesar mug shot bomberWebTheseus Pharmaceuticals, Inc. THRX i Nasdaq 8,333,500 shares (100% primary) $14.00 to $16.00 per share $125 million (assuming midpoint of IPO pricing range and excluding Overallotment Option) 1,250,025 shares (15% of the base offering shares) The Company intends to use the net proceeds from this offering. cesar millan my story unleashedWebin the reports Theseus files with the Securities and Exchange Commission (SEC), including Theseus' Form 10K for the year ended - December 31, 2024 filed with the SEC on March 10, 2024 and Theseus' Form 10Q for the quarter ended March 31, - 2024 filed with the SEC in the second quarter of 2024. However, new risk factors and uncertainties cesar millan slip lead leash canadaWebGet Brad Dahms's email address (b*****@theseusrx.com) and phone number (302540....) at RocketReach. Get 5 free searches. Rocketreach finds email, phone & social media for … buzz 2022 light yearWebBrad Dahms is Chief Financial Officer of Theseus Pharmaceuticals. Brad most recently served as Chief Financial Officer of Selecta Biosciences, Inc. (NASDAQ: SELB), where … cesar millan ranch addressWebBrad Dahms is Chief Financial Officer at Theseus Pharmaceuticals Inc. See Brad Dahms's compensation, career history, education, & memberships. ces army civilian website loginWebNov 30, 2024 · What is Bradford D. Dahms' net worth? The estimated net worth of Bradford D. Dahms is at least $59,208.88 as of November 30th, 2024. Mr. Dahms owns 6,142 … cesar millan puppy biting training